Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Helen J Ross
Affiliation
Mayo Clinic
ORCID
Career Start Year
1982
Papers
86
H Index
33
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
35194958
Gastroesophageal reflux disease and paraneoplastic neurological syndrome associated with long-term survival in limited stage small-cell lung cancer.
Thorac Cancer
2022
35392854
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer.
BMC Cancer
2022
35362092
Field cancerization in breast cancer.
J Pathol
2022
35927150
The molecular landscape of pancreatic ductal adenocarcinoma.
Pancreatology
2022
33477882
The Transcriptomic Landscape of Prostate Cancer Development and Progression: An Integrative Analysis.
Cancers (Basel)
2021
33739449
Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma.
Int J Cancer
2021
33451936
Molecular profiling of ctDNA in pancreatic cancer: Opportunities and challenges for clinical application.
Pancreatology
2021
32885042
Characterization of four subtypes in morphologically normal tissue excised proximal and distal to breast cancer.
NPJ Breast Cancer
2020
31764021
Expanding the Spectrum of Radiation Necrosis After Stereotactic Radiosurgery (SRS) for Intracranial Metastases From Lung Cancer: A Retrospective Review.
Am J Clin Oncol
2020
33083649
Acute Toxicities and Short-Term Patient Outcomes After Intensity-Modulated Proton Beam Radiation Therapy or Intensity-Modulated Photon Radiation Therapy for Esophageal Carcinoma: A Mayo Clinic Experience.
Adv Radiat Oncol
2020
32887725
Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors.
Clin Cancer Res
2020
28981577
'Multi-omic' data analysis using O-miner.
Brief Bioinform
2019
32529140
Early Outcomes of Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiation Therapy: The Mayo Clinic Experience.
Adv Radiat Oncol
2019
31155475
Small-cell Lung Cancer in Very Elderly (â¿¥ 80 Years) Patients.
Clin Lung Cancer
2019
30755501
A Case of Donor-Transmitted Non-Small Cell Lung Cancer After Liver Transplantation: An Unwelcome Guest.
Oncologist
2019
30476477
Expert Consensus Document on Pulmonary Metastasectomy.
Ann Thorac Surg
2019
28753852
DESNT: A Poor Prognosis Category of Human Prostate Cancer.
Eur Urol Focus
2018
30023104
Stereotactic body radiotherapy for early-stage non-small cell lung cancer has low post-treatment mortality.
J Thorac Dis
2018
29674442
First Report of Dramatic Tumor Responses with Ramucirumab and Paclitaxel After Progression on Pembrolizumab in Two Cases of Metastatic Gastroesophageal Adenocarcinoma.
Oncologist
2018
27815082
Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors.
Eur Urol
2017
28292578
Corrigendum to "Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study" [EBioMedicine 2 (9) (2015) 1133-1144].
EBioMedicine
2017
28286059
Mining Human Prostate Cancer Datasets: The "camcAPP" Shiny App.
EBioMedicine
2017
28089762
Long-Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non-Small Cell Lung Cancer: NCCTG N0028 (Alliance).
J Thorac Oncol
2017
29258618
A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer.
J Immunother Cancer
2017
28859365
Incidence of brain metastasis from esophageal cancer.
Dis Esophagus
2017
25824527
Incidence and impact of postoperative atrial fibrillation after minimally invasive esophagectomy.
Dis Esophagus
2016
26572708
The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer.
Eur Urol
2016
27732966
HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer.
Oncotarget
2016
27694157
A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer.
Oncologist
2016
27247118
Past approaches and future directions for targeting tumor hypoxia in squamous cell carcinomas of the head and neck.
Crit Rev Oncol Hematol
2016
26859444
The genetic classification of prostate cancer: what's on the horizon?
Future Oncol
2016
26881390
A genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese population.
Oncotarget
2016
27061083
Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic.
Radiat Oncol
2016
26950096
Gene regulatory mechanisms underpinning prostate cancer susceptibility.
Nat Genet
2016
25371077
PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-small-cell lung cancer.
J Thorac Oncol
2015
26501111
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study.
EBioMedicine
2015
26108458
A new scoring system for predicting survival in patients with non-small cell lung cancer.
Cancer Med
2015
25548099
Salt-inducible kinase 2 regulates mitotic progression and transcription in prostate cancer.
Mol Cancer Res
2015
25560400
HES5 silencing is an early and recurrent change in prostate tumourigenesis.
Endocr Relat Cancer
2015
24266955
Outcomes of minimally invasive esophagectomy in esophageal cancer after neoadjuvant chemoradiotherapy.
Ann Thorac Surg
2014
25456371
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study.
Lancet Oncol
2014
24997137
Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer.
Lung Cancer
2014
25047675
Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma.
Lung Cancer
2014
25157767
NCCTG N0821 (Alliance): a phase II first-line study of pemetrexed, carboplatin, and bevacizumab in elderly patients with advanced nonsquamous non-small-cell lung cancer with good performance status.
J Thorac Oncol
2014
24737870
HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle network.
EMBO Mol Med
2014
23232491
A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North Central Cancer Treatment Group Study N0528.
J Thorac Oncol
2013
22333598
A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer.
Br J Cancer
2012
22730461
Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis.
Proc Natl Acad Sci U S A
2012
22782333
Prophylactic cranial irradiation in small-cell lung cancer: findings from a North Central Cancer Treatment Group Pooled Analysis.
Ann Oncol
2012
22306652
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke.
Nat Genet
2012
1 - 50 of 86
Column Actions
Search
Recommended Authors
Jyoti Malhotra
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year
2012
Number of shared co-authors
3
Chen Hu
Johns Hopkins University School of Medicine
Career Start Year
2009
Number of shared co-authors
2
Ashiq Masood
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Career Start Year
2008
Number of shared co-authors
2
Fiona Blackhall
The University of Manchester
Career Start Year
2000
Number of shared co-authors
8
Shane White
Olivia Newton-John Cancer Wellness and Research Centre
Career Start Year
2000
Number of shared co-authors
3
Pingfu Fu
Case Western Reserve University
Career Start Year
2000
Number of shared co-authors
7
Daniel Morgensztern
Washington University School of Medicine
Career Start Year
2000
Number of shared co-authors
4
Elisabeth I Heath
Karmanos Cancer Center, Wayne State University
Career Start Year
1999
Number of shared co-authors
7
David J Liewehr
Center for Cancer Research
Career Start Year
1999
Number of shared co-authors
1
Primo N Lara
University of California Davis Comprehensive Cancer Center
Career Start Year
1996
Number of shared co-authors
8
Puneeth Iyengar
UT Southwestern Medical Center, Center for Human Nutrition
Career Start Year
1996
Number of shared co-authors
1
Lillian L Siu
Princess Margaret Cancer Centre, University Ave
Career Start Year
1995
Number of shared co-authors
12
Stefan Sleijfer
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year
1994
Number of shared co-authors
3
Kevin Camphausen
National Cancer Institute
Career Start Year
1994
Number of shared co-authors
2
Vincent A Miller
Injury Prevention Research Center, University of North Carolina
Career Start Year
1994
Number of shared co-authors
5
Paul Mitchell
Olivia Newton-John Cancer Research Institute
Career Start Year
1993
Number of shared co-authors
4
Michael Allg??uer
Institute of Pathology, Heidelberg University Hospital
Career Start Year
1991
Number of shared co-authors
0
Suresh Nair
Lehigh Valley Topper Cancer Institute
Career Start Year
1990
Number of shared co-authors
2
Emile E Voest
The Netherlands Cancer Institute
Career Start Year
1989
Number of shared co-authors
1
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year
1988
Number of shared co-authors
12
Jose A Lopez-Martin
Hospital Universitario 12 de Octubre
Career Start Year
1988
Number of shared co-authors
0
David S Schrump
Center for Cancer Research, National Cancer Institute
Career Start Year
1988
Number of shared co-authors
0
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Career Start Year
1986
Number of shared co-authors
3
Roy S Herbst
Yale School of Medicine
Career Start Year
1984
Number of shared co-authors
6
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Career Start Year
1984
Number of shared co-authors
3
Giuseppe Giaccone
Meyer Cancer Center
Career Start Year
1981
Number of shared co-authors
8
James H Doroshow
National Cancer Institute, National Institutes of Health
Career Start Year
1974
Number of shared co-authors
4
Antonio Jimeno
University of Colorado School of Medicine
Career Start Year
1974
Number of shared co-authors
5
Ming-Sound Tsao
University Health Network, University of Toronto
Career Start Year
1972
Number of shared co-authors
26
John D Minna
University of Texas Southwestern Medical Center at Dallas
Career Start Year
1967
Number of shared co-authors
11
row(s) 1 - 30 of 30
Collaborators
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers
14
Alastair D Lamb
University of Oxford
Co-authored papers
12
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Co-authored papers
10
Ian G Mills
Queen's University Belfast
Co-authored papers
9
Mark J Dunning
The Medical School, The University of Sheffield
Co-authored papers
8
Hayley C Whitaker
University College London
Co-authored papers
7
Charlie E Massie
University of Cambridge
Co-authored papers
6
Colin S Cooper
Norwich Medical School, University of East Anglia
Co-authored papers
6
Andy G Lynch
University of St Andrews
Co-authored papers
6
Silvia Halim
University of Oxford
Co-authored papers
6
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers
5
Jonathan Kay
University College London
Co-authored papers
5
Johan Lindberg
Karolinska Institute
Co-authored papers
4
Henrik Gr??nberg
Karolinska Institute
Co-authored papers
4
Lars Egevad
Karolinska Institute
Co-authored papers
4
Ping Yang
Mayo Clinic
Co-authored papers
3
Nimish Shah
Cambridge University Hospitals NHS Foundation Trust
Co-authored papers
3
Jeremy Clark
Norwich Medical School, University of East Anglia
Co-authored papers
3
Emilie Lalonde
University of Pennsylvania
Co-authored papers
3
Paul C Boutros
University of California los angeles
Co-authored papers
3
Pasi A J??nne
Dana-Farber Cancer Institute
Co-authored papers
3
Hayley J Luxton
University College London
Co-authored papers
2
Robert G Bristow
University of Toronto
Co-authored papers
2
Angelina D Tan
Mayo Clinic
Co-authored papers
2
Braxton D Mitchell
Co-authored papers
2
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
2
Cindy Q Yao
Ontario Institute for Cancer Research
Co-authored papers
2
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
2
Frances A Shepherd
University Health Network, Princess Margaret Cancer Centre
Co-authored papers
2
Zsofia Kote-Jarai
The Institute of Cancer Research
Co-authored papers
2
1 - 30